Randomized controlled trial of sativex, a cannabis based medicine (CBM), in central neuropathic pain due to multiple sclerosis, followed by an open-label extension

Category Primary study
JournalNeurology
Year 2006


This article has no abstract

Epistemonikos ID: 9faf42f3d46fab9a283613db0814a2a409ba22fc

By using Epistemonikos Database, you agree to our Terms and Conditions and Privacy Policy

I accept